Current therapeutic principles in the acute management of severe congestive heart failure (Q39516616)

12 September 2017

1 reference

title

Current therapeutic principles in the acute management of severe congestive heart failure (English)

1 reference

12 September 2017

0 references

congestive heart failure

1 reference

Poole-Wilson PA

1

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 August 1988

1 reference

American Journal of Cardiology

12 September 2017

published in

1 reference

12 September 2017

volume

62

1 reference

12 September 2017

issue

5

1 reference

12 September 2017

page(s)

4C-8C

1 reference

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Alterations in vasomotor tone in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Evolution and the cardiac patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Evolution and the cardiac patient.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Evolution and the cardiac patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Congestive cardiac failure: central role of the arterial blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Sodium and water excretion in heart failure: efficacy of treatment has surpassed knowledge of pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Heterogeneous myocardial catecholamine concentrations in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Decreased Lymphocyte Beta-Adrenergic-Receptor Density in Patients with Heart Failure and Tolerance to the Beta-Adrenergic Agonist Pirbuterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Inotropic and vasodilator effects of amrinone on isolated human tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Reduced positive inotropic effects in diseased human ventricular myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Intact systolic left ventricular function in clinical congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

The pathogenesis of clinical and experimental congestive cardiomyopathies: recent concepts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Abnormalities of skeletal muscle in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril, and nitrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Effects of isoproterenol on heart muscle performance during myocardial hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Hemodynamics, coronary blood flow, and myocardial metabolism in coronary shock; response of 1-norepinephrine and isoproterenol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Effect of dopamine on hemodynamics and myocardial metabolism in shock following acute myocardial infarction in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Effects of dopamine on myocardial metabolism in patients with ischaemic heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

Symptoms limiting exercise in chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980060-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(88)80060-2

1 reference

12 September 2017

1 reference